CVE-2017-17678

MEDIUM

6.1

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Details CVE

Score CVSS v3.16.1

SeveriteMEDIUM

Vecteur CVSSCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Vecteur d'attaqueNETWORK

ComplexiteLOW

Privileges requisNONE

Interaction utilisateurREQUIRED

Publie5/19/2021

Derniere modification11/21/2024

Sourcenvd

Observations honeypot0

Produits affectes

bmc:remedy_mid-tier

Faiblesses (CWE)

CWE-79

References

http://bmc.com(cve@mitre.org)

http://remedy.com(cve@mitre.org)

https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html(cve@mitre.org)

https://seclists.org/fulldisclosure/2017/Oct/52(cve@mitre.org)

http://bmc.com(af854a3a-2127-422b-91ae-364da2661108)

http://remedy.com(af854a3a-2127-422b-91ae-364da2661108)

https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html(af854a3a-2127-422b-91ae-364da2661108)

https://seclists.org/fulldisclosure/2017/Oct/52(af854a3a-2127-422b-91ae-364da2661108)

Correlations IOC

Aucune correlation enregistree

This product uses data from the NVD API but is not endorsed or certified by the NVD.